<!doctype html>
<html>
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width">
<title></title>
<link rel="stylesheet" href="css/style.css">
</head>

<body>

<header>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <p class="title"><a href="index.html">社外秘 研修資料</a></p>
  <div class="r"><a href="044.html"><span>right</span></a></div>
</header>

<div class="wrap">
  <div class="clearfix">
  <img src="img04/multi.png" alt="マルチスタジオ非掲載" width="110" height="20" style="float: right;">
</div>
  <section>
    <p class="pagesubtit"><strong>対オレンシア③有効性</strong></p>
    <h1 class="tit">産業医科大学のプロペンシティスコア（PS）マッチングの結果、ABTとTCZの継続率・有効性は同等であったという報告がある</h1>
  </section>

  <section>
    <ul class="circle">
    	<li><span>●</span>産業医科大学の実臨床下でABTもしくはTCZが投与されたRA患者の1年後の臨床結果を比較した</li>
    	<li><span>●</span>ABT194名、TCZ273名をマッチングさせそれぞれ102名ずつ抽出し、SDAI・HAQ等を比較したところ同等であった</li>
    </ul>
    <div class="table">
      <p class="tit">PSマッチング<span class="red">前</span></p>
      <div class="sc">
        <table class="style1 color_green">
          <tr>
            <th>　</th>
            <th>ABT<br/>（n=194）</th>
            <th>TCZ<br/>（n=273）</th>
            <th>p-value</th>
          </tr>
          <tr>
            <td class="left">年齢(歳)</td>
            <td>63</td>
            <td>59.2</td>
            <td>&lt;0.05</td>
          </tr>
          <tr>
            <td class="left">Bio使用歴(%)</td>
            <td>51</td>
            <td>32.3</td>
            <td>&lt;0.05</td>
          </tr>
          <tr>
            <td class="lbd_red tbd_red left"><strong>MTX併用(％)</strong></td>
            <td class="tbd_red"><strong>70.1</strong></td>
            <td class="tbd_red"><font color="red"><strong>59.3</strong></font></td>
            <td class="rbd_red tbd_red"><strong>&lt;0.05</strong></td>
          </tr>
          <tr>
            <td class="lbd_red left"><strong>MMP-3（ng/mL）</strong></td>
            <td><strong>175.3</strong></td>
            <td><font color="red"><strong>351.9</strong></font></td>
            <td class="rbd_red"><strong>&lt;0.001</strong></td>
          </tr>
          <tr>
            <td class="lbd_red left"><strong>CRP(mg/dL)</strong></td>
            <td><strong>1.5</strong></td>
            <td><font color="red"><strong>3.4</strong></font></td>
            <td class="rbd_red"><strong>&lt;0.001</strong></td>
          </tr>
          <tr>
            <td class="lbd_red left"><strong>RF(U/mL)</strong></td>
            <td><strong>148</strong></td>
            <td><font color="red"><strong>203</strong></font></td>
            <td class="rbd_red"><strong>&lt;0.05</strong></td>
          </tr>
          <tr>
            <td class="lbd_red left"><strong>SDAI</strong></td>
            <td><strong>26</strong></td>
            <td><font color="red"><strong>32</strong></font></td>
            <td class="rbd_red"><strong>&lt;0.001</strong></td>
          </tr>
          <tr>
            <td class="lbd_red left"><strong>CDAI</strong></td>
            <td><strong>24.5</strong></td>
            <td><font color="red"><strong>27.7</strong></font></td>
            <td class="rbd_red"><strong>0.01</strong></td>
          </tr>
          <tr>
            <td class="lbd_red bbd_red "><strong>DAS28-ESR</strong></td>
            <td class="bbd_red"><strong>5.3</strong></td>
            <td class="bbd_red"><font color="red"><strong>5.8</strong></font></td>
            <td class="rbd_red bbd_red "><strong>&lt;0.001</strong></td>
          </tr>
        </table>
      </div>
    </div>
    <div class="table">
      <p class="tit">PSマッチング<span class="blue">後</span></p>
      <div class="sc">
        <table class="style1 color_org">
          <tr>
            <th>　</th>
            <th>ABT<br/>（n=194）</th>
            <th>TCZ<br/>（n=273）</th>
            <th>p-value</th>
          </tr>
          <tr>
            <td class="left">年齢(歳)</td>
            <td>60.7</td>
            <td>59.2</td>
            <td>0.45</td>
          </tr>
          <tr>
            <td class="left">Bio使用歴(%)</td>
            <td>54.9</td>
            <td>59.8</td>
            <td>0.57</td>
          </tr>
          <tr>
            <td class="left">MTX併用(％)</td>
            <td>66.7</td>
            <td>64.7</td>
            <td>0.88</td>
          </tr>
          <tr>
            <td class="left">MMP-3（ng/mL）</td>
            <td>236</td>
            <td>205</td>
            <td>0.21</td>
          </tr>
          <tr>
            <td class="left">CRP(mg/dL)</td>
            <td>2.1</td>
            <td>2</td>
            <td>0.67</td>
          </tr>
          <tr>
            <td class="left">RF(U/mL)</td>
            <td>166</td>
            <td>177</td>
            <td>0.82</td>
          </tr>
          <tr>
            <td class="left">SDAI</td>
            <td>28.7</td>
            <td>27.7</td>
            <td>0.6</td>
          </tr>
          <tr>
            <td class="left">CDAI</td>
            <td>26.6</td>
            <td>25.8</td>
            <td>0.63</td>
          </tr>
          <tr>
            <td class="left">DAS28-ESR</td>
            <td>5.7</td>
            <td>5.6</td>
            <td>0.46</td>
          </tr>
        </table>
      </div>
    </div>
    <div class="img"><img src="img/50-1.png" alt=""></div>
    <div class="greenbox"><p>PSmatching前のTCZ群は、ABT群に比べMTX併用が少なく、MMP-3が高く関節破壊が進んでおり、疾患活動性も高い患者群であるが、Matching後はこのような重症例に使用した結果は反映されていない。</p></div>
    <p class="text sml right"><a href="http://maps.ty.chugai-pharm.co.jp/Search/Detail.aspx?id=E39255&skey=0bc9eaed-f165-43f5-8a35-caf219486674">Kubo S et.al;Ann Rheum Dis. 2016 Jul;75(7):1321-7</a></p>
  </section>

</div>

<footer>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <div class="home"><a href="index.html"><span>HOME</span></a></div>
  <div class="r"><a href="044.html"><span>right</span></a></div>
  <div class="pagetop"><a href="javascript:scroll(0,0);">pagetop</a></div>
</footer>

<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js"></script>
<script src="js/common.js"></script>
</body>
</html>
